ArticleCommunications medicine2023

Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review.

Katherine G Young et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.